Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16‐week, randomized, double‐blind, active control trial *
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
Institutions: China-Japan Friendship Hospital, Wuhan Union Hospital, Xijing Hospital, Air Force Medical University, First Affiliated Hospital of Harbin Medical University, Nanjing First Hospital, All India Institute of Medical Sciences, Manipal Hospital, Samsung Medical Center, Sungkyunkwan University, Catholic University of Korea, Novo Nordisk (Denmark)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1928513790
